secwatch.observer — SEC 8-K summary
======================================

Issuer:     INOVIO PHARMACEUTICALS, INC. (INO)
CIK:        0001055726
Form:       8-K
Filed at:   2024-08-13T23:59:59+00:00
Accession:  0001193125-24-199331
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

INOVIO enters $60M at-the-market equity distribution agreement with Oppenheimer
-------------------------------------------------------------------------------

- Sales agreement enables INOVIO to sell up to $60M of common stock via Oppenheimer as agent.
- Commission of up to 3% of gross proceeds; INOVIO may suspend or terminate offering at any time.
- Shares sold under existing S-3 registration statement; proceeds for general corporate purposes.
- No obligation to sell any shares; sales are at INOVIO's sole discretion and subject to market conditions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1055726/000119312524199331/0001193125-24-199331-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1055726/000119312524199331/d761691d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-199331

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer